Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia

CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company ...

First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine

First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine ...

ThreatBook Peer-Recognized as a Strong Performer in the 2025 Gartner(R) Peer Insights(TM) Voice of the Customer for Network Detection and Response -- for the Third Consecutive Year

SINGAPORE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- ThreatBook, a global leader in threat intelligence-based cybersecurity solutions, today announced that for its Threat Detection Platform (TDP), it has been ...
News Medical

Study reveals how TDP-43 causes neuronal overactivity in ALS and FTD

A new Northwestern University study using patient nervous tissue and lab-grown human neurons has uncovered how a key disease protein, TDP-43, drives overactive nerve cells in the neurodegenerative ...